May 2, 2023
Kristina Storey joined Fulcrum in November 2022 as senior vice president, head of regulatory affairs and quality assurance. Kristina brings over two decades of experience maximizing the value of complex clinical programs and leading successful global regulatory interactions across multiple therapeutic areas.
Most recently, Kristina was vice president of regulatory affairs at Pharvaris, a clinical-stage biopharmaceutical company focused on advancing small-molecule alternatives for patients with hereditary angioedema and other bradykinin B2-receptor-mediated indications. Prior to that she held roles of increasing responsibility at Momenta Pharmaceuticals and served as the vice president and head of regulatory affairs at the time of its acquisition by Johnson & Johnson.
Kristina holds a Regulatory Affairs Certification and received a Bachelor of Arts degree from the University of New Hampshire.